{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:11:01Z","timestamp":1793880661499,"version":"4.7.0"},"reference-count":22,"publisher":"American Diabetes Association","issue":"9","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To evaluate the association between fear and perceived frequency of hypoglycemia and continuous glucose monitoring (CGM) metrics in adults with type 1 diabetes using diabetes technology over 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>This retrospective explorative analysis evaluated correlations between hypoglycemia fear, perceived hypoglycemia frequency, and CGM metrics in 1,370 adults with type 1 diabetes using real-time CGM (Comparing Continuous With Flash Glucose Monitoring in Adults With Type 1 Diabetes [ALERTT1] study, n = 254) or hybrid closed-loop (The Impact of Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMs [INRANGE] studies, n = 1,116) for 12 months. Hypoglycemia fear was assessed with the Hypoglycemia Fear Survey II worry (HFS-worry) and behavior (HFS-behavior) subscales and perceived hypoglycemia frequency with the hypoglycemia subscale of the Diabetes Treatment Satisfaction Questionnaire\u2013status (DTSQs-hypo). Data are reported as mean \u00b1 SD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>At baseline (before the start of technology), mean age was 41.0 \u00b1 13.7 years, 55.9% were women, diabetes duration was 21.6 \u00b1 12.7 years, HbA1c was 7.6 \u00b1 1.0% (59.0 \u00b1 10.8 mmol\/mol), and time in 3.9\u201310.0 mmol\/L was 61.1 \u00b1 15.5%. Over 12 months, time &amp;lt;3.9\/&amp;lt;3.0 mmol\/L decreased from 3.4 \u00b1 3.5%\/0.8 \u00b1 1.4% to 2.3 \u00b1 2.2%\/0.5 \u00b1 0.7%, while HFS-worry (21.0 \u00b1 12.9 to 16.8 \u00b1 12.1) and DTSQs-hypo (3.3 \u00b1 1.5 to 2.7 \u00b1 1.4) also decreased. HFS-worry, HFS-behavior, and DTSQs-hypo showed no clear correlations with time in hypoglycemia or other CGM metrics at baseline, at 12 months, or over 12-month change.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>In adults using diabetes technology over 12 months, fear and perceived frequency of hypoglycemia showed no clear correlations with CGM metrics, suggesting both are influenced by more than glycemic profiles alone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc26-0763","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T18:31:59Z","timestamp":1783362719000},"page":"1637-1644","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":1,"title":["The Correlation Between Fear and Perceived Frequency of Hypoglycemia and Continuous Glucose Monitoring Metrics in Adults With Type 1 Diabetes Using Diabetes Technology: A 1-Year Analysis"],"prefix":"10.2337","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2501-6554","authenticated-orcid":false,"given":"Laura","family":"Valgaerts","sequence":"first","affiliation":[{"name":"Department of Endocrinology, University Hospitals Leuven\u2013Department of Clinical and Experimental Endocrinology 1 , KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6007-6715","authenticated-orcid":false,"given":"Jolien","family":"De Meulemeester","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospitals Leuven\u2013Department of Clinical and Experimental Endocrinology 1 , KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0216-4028","authenticated-orcid":false,"given":"Margaretha M.","family":"Visser","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospitals Leuven\u2013Department of Clinical and Experimental Endocrinology 1 , KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2100-4927","authenticated-orcid":false,"given":"Sara","family":"Charleer","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospitals Leuven\u2013Department of Clinical and Experimental Endocrinology 1 , KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Fieuws","sequence":"additional","affiliation":[{"name":"Interuniversity Institute for Biostatistics and Statistical Bioinformatics, KU Leuven and University of Hasselt 2 , Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Keymeulen","sequence":"additional","affiliation":[{"name":"Department of Diabetology and Endocrinology, University Hospital Brussels 3 , Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"De Block","sequence":"additional","affiliation":[{"name":"Department of Endocrinology-Diabetology, University Hospital Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences 4 , Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6099-2406","authenticated-orcid":false,"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospitals Leuven\u2013Department of Clinical and Experimental Endocrinology 1 , KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9690-3551","authenticated-orcid":false,"given":"Kristina","family":"Casteels","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospitals Leuven\u2013Department of Development and Regeneration 5 , KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9111-4561","authenticated-orcid":false,"given":"Pieter","family":"Gillard","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospitals Leuven\u2013Department of Clinical and Experimental Endocrinology 1 , KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"2026082014532899500_B1","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/S0140-6736(16)31535-5","article-title":"Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial","volume":"388","author":"Bolinder","year":"2016","journal-title":"Lancet"},{"key":"2026082014532899500_B2","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00125-020-05366-3","article-title":"The consequences of hypoglycaemia","volume":"64","author":"Amiel","year":"2021","journal-title":"Diabetologia"},{"key":"2026082014532899500_B3","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00592-018-1172-5","article-title":"Prevalence and predictors of depression and anxiety in adult patients with type 1 diabetes in tertiary care setting","volume":"55","author":"Castellano-Guerrero","year":"2018","journal-title":"Acta Diabetol"},{"key":"2026082014532899500_B4","doi-asserted-by":"crossref","first-page":"e2633","DOI":"10.1002\/brb3.2633","article-title":"Fear of hypoglycemia\u2014an underestimated problem","volume":"12","author":"Przezak","year":"2022","journal-title":"Brain Behav"},{"key":"2026082014532899500_B5","doi-asserted-by":"crossref","first-page":"1563410","DOI":"10.3389\/fendo.2025.1563410","article-title":"Fear of hypoglycemia is linked to poorer glycemic control and reduced quality of life in adults with type 1 diabetes","volume":"16","author":"Mesa D\u00edaz","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026082014532899500_B6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5603\/DK.2020.0046","article-title":"Fear of hypoglycaemia \u2014 from normality to pathology. Diagnostic criteria and therapeutic directions","volume":"9","author":"Krawczyk","year":"2020","journal-title":"Clin Diabetol"},{"key":"2026082014532899500_B7","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1210\/jc.2017-02498","article-title":"Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study","volume":"103","author":"Charleer","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026082014532899500_B8","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0140-6736(21)00789-3","article-title":"Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial","volume":"397","author":"Visser","year":"2021","journal-title":"Lancet"},{"key":"2026082014532899500_B9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/pedi.13150","article-title":"Fear of hypoglycemia in children with type 1 diabetes and their parents: effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial","volume":"22","author":"Verbeeten","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"2026082014532899500_B10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12916-024-03396-x","article-title":"Long-term assessment of the NHS hybrid closed-loop real-world study on glycaemic outcomes, time-in-range, and quality of life in children and young people with type 1 diabetes","volume":"22","author":"Ng","year":"2024","journal-title":"BMC Med"},{"key":"2026082014532899500_B11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s00125-025-06366-x","article-title":"One-year real-world benefits of Tandem Control-IQ technology on glucose management and person-reported outcomes in adults with type 1 diabetes: a prospective observational cohort study","volume":"68","author":"De Meulemeester","year":"2025","journal-title":"Diabetologia"},{"key":"2026082014532899500_B12","doi-asserted-by":"crossref","first-page":"e15280","DOI":"10.1111\/dme.15280","article-title":"Comparing the glycaemic outcomes between real-time continuous glucose monitoring (rt-CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"41","author":"Zhou","year":"2024","journal-title":"Diabet Med"},{"key":"2026082014532899500_B13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/dia.2022.0558","article-title":"A meta-analysis of randomized trial outcomes for the t:slim X2 insulin pump with Control-IQ technology in youth and adults from age 2 to 72","volume":"25","author":"Beck","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2026082014532899500_B14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2213-8587(22)00352-7","article-title":"Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial","volume":"11","author":"Visser","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026082014532899500_B15","doi-asserted-by":"crossref","first-page":"102119","DOI":"10.1016\/j.eclinm.2023.102119","article-title":"Effect of diabetes technologies on the fear of hypoglycaemia among people living with type 1 diabetes: a systematic review and meta-analysis","volume":"62","author":"Talbo","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2026082014532899500_B16","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2337\/dc23-2332","article-title":"Relationship between sensor-detected hypoglycemia and patient-reported hypoglycemia in people with type 1 and insulin-treated type 2 diabetes: the Hypo-METRICS study","volume":"47","author":"Divilly","year":"2024","journal-title":"Diabetes Care"},{"key":"2026082014532899500_B17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2337\/dc21-1120","article-title":"Hypoglycemia subtypes in type 1 diabetes: an exploration of the Hypoglycemia Fear Survey-II","volume":"45","author":"Maclean","year":"2022","journal-title":"Diabetes Care"},{"key":"2026082014532899500_B18","doi-asserted-by":"crossref","first-page":"108752","DOI":"10.1016\/j.diabres.2021.108752","article-title":"The impact of hypoglycaemia on quality of life outcomes among adults with type 1 diabetes: a systematic review","volume":"174","author":"Chatwin","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"2026082014532899500_B19","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jdiacomp.2019.05.003","article-title":"No association between fear of hypoglycemia and blood glucose variability in type 1 diabetes: the cross-sectional VARDIA study","volume":"33","author":"Saulnier","year":"2019","journal-title":"J Diabetes Complications"},{"key":"2026082014532899500_B20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc10-1343","article-title":"Psychometric properties of the Hypoglycemia Fear Survey-II for adults with type 1 diabetes","volume":"34","author":"Gonder-Frederick","year":"2011","journal-title":"Diabetes Care"},{"key":"2026082014532899500_B21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1089\/dia.2020.0016","article-title":"Associations between the time in hypoglycemia and hypoglycemia awareness status in type 1 diabetes patients using continuous glucose monitoring systems","volume":"22","author":"Lin","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"2026082014532899500_B22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2337\/dc24-1833","article-title":"Time below range and its influence on hypoglycemia awareness and severe hypoglycemia: insights from the Association of British Clinical Diabetologists Study","volume":"48","author":"Deshmukh","year":"2025","journal-title":"Diabetes Care"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/9\/1637\/887872\/dc260763.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/9\/1637\/887872\/dc260763.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T18:53:45Z","timestamp":1787252025000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/9\/1637\/172132\/The-Correlation-Between-Fear-and-Perceived"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,7,6]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc26-0763","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]}}}